Check out our most popular compounded medications! Get Started
Chlorpheniramine Maleate 8 mg Slow Release Capsules are formulated with Methocel E4M, a controlled-release polymer. This design allows for the gradual release of the active ingredient over an extended period, providing sustained therapeutic effects. This formulation is used to treat conditions such as Allergic Rhinitis, Urticaria, Pruritus, Asthma, and Angioedema. The slow release mechanism reduces dosing frequency and improves patient compliance for medications requiring a controlled and prolonged release profile.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Chlorpheniramine Maleate 8 mg Slow Release Capsules is a specialized medication designed to treat a variety of allergic and respiratory conditions. This antihistamine works by blocking the action of histamine, a chemical released by the body during an allergic reaction. The formulation is encapsulated with Methocel E4M, a type of controlled-release polymer, which ensures a gradual release of the active ingredient over an extended period of time. This slow and steady release allows for sustained therapeutic effects, reduced dosing frequency, and improved patient compliance, particularly beneficial for medications requiring a controlled and prolonged release profile.
Indicated for the treatment of hay fever, allergic rhinitis, urticaria, and other allergic conditions, Chlorpheniramine Maleate 8 mg Slow Release Capsules also provide relief for symptoms associated with the common cold and upper respiratory tract infections. The formulation is available in 8 mg capsules and is to be taken orally, with or without food, as directed by a healthcare provider. The recommended dose is 8 mg once daily, or as per healthcare provider's instructions. It is important to note that patients should not exceed the recommended dose and should not take more than one dose in 24 hours.
While Chlorpheniramine Maleate 8 mg Slow Release Capsules is generally well tolerated, it may cause side effects such as drowsiness, dry mouth, and dizziness. Patients are advised not to drive or operate machinery until they understand how this medication affects them. Additionally, alcohol should be avoided while taking this medication.
If you have any questions or need further information about Chlorpheniramine Maleate 8 mg Slow Release Capsules, please do not hesitate to reach out to us at Bayview Pharmacy. We are here to assist you with your healthcare needs.
Chlorpheniramine Maleate 8 mg Slow Release Capsules, formulated with Methocel E4M, a controlled-release polymer, are designed to gradually release the active ingredient over an extended period. This formulation offers sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile.
It's important to note that these capsules may interact with other medications, including those used to treat asthma, allergies, colds, and flu. Patients are advised to inform their healthcare provider of all medications they are currently taking, including over-the-counter medications, vitamins, and herbal supplements. Additionally, patients should disclose any known allergies to medications, including chlorpheniramine maleate.
Patients taking Chlorpheniramine Maleate 8 mg Slow Release Capsules should avoid alcohol and other sedatives, as these can enhance the sedative effects of the medication. It's also recommended to avoid other medications containing antihistamines to prevent an increased risk of side effects.
Furthermore, this medication may interact with certain asthma treatments, such as beta-agonists and theophylline. If patients are taking any of these medications, they should inform their healthcare provider. Similarly, interactions may occur with allergy medications like cromolyn sodium and leukotriene modifiers, as well as cold and flu treatments such as decongestants and cough suppressants.
If you have any questions about the interactions of Chlorpheniramine Maleate 8 mg Slow Release Capsules with other medications, please consult with your healthcare provider or pharmacist for further guidance.
Chlorpheniramine Maleate 8 mg Slow Release Capsules are a specialized formulation designed to treat a variety of conditions such as allergies, hay fever, and the common cold. The active ingredient, chlorpheniramine maleate, is encapsulated in a controlled-release polymer, Methocel E4M, which ensures a gradual and sustained release of the medication over an extended period of time. This slow-release mechanism offers consistent therapeutic effects, reduces the need for frequent dosing, and enhances patient compliance, particularly for those requiring a controlled and prolonged release profile.
The capsules are administered orally, typically once or twice a day, depending on the severity of the symptoms. They should be swallowed whole with a glass of water, and it is crucial to take them at the same time each day to maintain a consistent release rate of the active ingredient. This ensures a steady level of relief from the symptoms associated with allergies, hay fever, and the common cold.
Chlorpheniramine maleate works by inhibiting the action of histamine, a chemical that the body releases during an allergic reaction. By blocking histamine, the medication effectively reduces the symptoms associated with these conditions, providing relief for the patient.
When taking Chlorpheniramine Maleate 8 mg Slow Release Capsules, it is essential to adhere to the instructions provided by your healthcare provider. Do not exceed or reduce the recommended dose, and do not continue the medication beyond the period recommended by your doctor. If you have any queries about the medication or its administration, please consult your healthcare provider or pharmacist.
Chlorpheniramine Maleate 8 mg Slow Release Capsules are meticulously formulated with Methocel E4M, a controlled-release polymer. This design ensures the gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects, reduced dosing frequency, and improved patient compliance. This formulation is particularly beneficial for medications requiring a controlled and prolonged release profile.
These capsules can be used to treat a variety of conditions including allergic conjunctivitis, allergic contact dermatitis, and drug-induced hypersensitivity reactions. The capsules can help reduce the severity of symptoms associated with the common cold, such as fever, body aches, and sore throat.
Furthermore, Chlorpheniramine Maleate 8 mg Slow Release Capsules can be used to alleviate symptoms associated with the flu and hay fever, such as sneezing, runny nose, and itchy eyes. However, it is crucial to note that this formulation should not be used to treat any condition other than those listed above without consulting a healthcare professional.
If you have any questions about the use of Chlorpheniramine Maleate 8 mg Slow Release Capsules, it is recommended to consult with a healthcare professional to ensure safe and appropriate use.
Chlorpheniramine Maleate 8 mg Slow Release Capsules is a medication formulated with Methocel E4M, a type of controlled-release polymer. This formulation is designed to release the encapsulated medication gradually over an extended period of time.
The controlled-release polymer, Methocel E4M, is designed to gradually release the medication over an extended period of time. This offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance for medications requiring a controlled and prolonged release profile.
Slow release capsules offer several benefits. They provide sustained therapeutic effects, reduce the need for frequent dosing, and improve patient compliance, especially for medications that require a controlled and prolonged release profile.
The slow release mechanism works by gradually releasing the medication over an extended period of time. This is achieved through the use of a controlled-release polymer, Methocel E4M, which encapsulates the medication and releases it slowly.
Methocel E4M is a type of controlled-release polymer used in the formulation of certain medications. It is designed to encapsulate the medication and release it gradually over an extended period of time.
Due to the slow release mechanism of this medication, the frequency of dosing is reduced. However, the exact dosing schedule should be determined by your healthcare provider based on your specific medical condition and response to therapy.
The therapeutic effect of Chlorpheniramine Maleate 8 mg Slow Release Capsules is sustained over an extended period of time due to the slow release mechanism of the medication. This helps to maintain a consistent level of medication in the body, providing ongoing relief from symptoms.
No, you should not break or chew the capsules. Doing so can interfere with the slow release mechanism of the medication and may lead to a sudden release of all the medication, which can increase the risk of side effects.
If you miss a dose of this medication, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose and resume your usual dosing schedule. Do not double the dose to catch up.
Like all medications, Chlorpheniramine Maleate 8 mg Slow Release Capsules can cause side effects. Common side effects may include drowsiness, dizziness, dry mouth, throat or nose. If any of these effects persist or worsen, notify your doctor or pharmacist promptly.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
